The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Danilov M.A.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

Streltsov Yu.A.

Clinical Research Center of Moscow

Leontev A.V.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

Kochergin V.G.

Clinical Research Center of Moscow

Klimashevich A.V.

Clinical Research Center of Moscow

Grinevich V.N.

Clinical Research Center of Moscow

Colectomy for fulminant pseudomembranous colitis following COVID-19. (A case report)

Authors:

Danilov M.A., Streltsov Yu.A., Leontev A.V., Kochergin V.G., Klimashevich A.V., Grinevich V.N.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2023;12(3): 117‑123

DOI: 10.17116/dokgastro202312031117

Read: 1854 times

Download PDF (RU)
Contact the author
Table of contents

COLECTOMY FOR FULMINANT PSEUDOMEMBRANOUS COLITIS FOLLOWING COVID-19. (A CASE REPORT)
COLECTOMY FOR FULMINANT PSEUDOMEMBRANOUS COLITIS FOLLOWING COVID-19. (A CASE REPORT)

To cite this article:

Danilov MA, Streltsov YuA, Leontev AV, Kochergin VG, Klimashevich AV, Grinevich VN. Colectomy for fulminant pseudomembranous colitis following COVID-19. (A case report). Russian Journal of Evidence-Based Gastroenterology. 2023;12(3):117‑123. (In Russ.)
https://doi.org/10.17116/dokgastro202312031117

Подписка 2026 Доказательная гастроэнтерология (Russian Journal of Evidence-Based Gastroenterology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Sele­ctive anosmia for mono­molecular odorants in a cohort of young indi­viduals. Russian Rhinology. 2024;(4):262-268
The resu­lts of the examination of patients with chro­nic gene­ralized periodontitis after novel coro­navirus infe­ction. Russian Journal of Stomatology. 2024;(4):18-22
Waiting for Disease X: a plan for preparing Russian labo­ratory services for the next pandemic. Labo­ratory Service. 2024;(4):5-11
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59
A clinical case of the aortic rupture after SARS-CoV-2 in the patient with Stickler syndrom. Russian Journal of Preventive Medi­cine. 2025;(3):103-106
Abstract:

One of the most common consequences for patients undergoing antibiotic therapy is a Clostridioides difficile infection. Generally, when conservative therapies are failing and the disease is progressing rapidly, surgery is recommended. However, mortality after urgent and emergency total or subtotal colectomy is very high. This clinical observation shows a 63-year-old patient who underwent an urgent colectomy for fulminant pseudomembranous colitis after receiving biologic therapy to treat severe COVID-19.

Keywords:

COVID-19
clostridioides difficile
pseudomembranous colitis
colectomy

Authors:

Danilov M.A.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

Streltsov Yu.A.

Clinical Research Center of Moscow

Leontev A.V.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

Kochergin V.G.

Clinical Research Center of Moscow

Klimashevich A.V.

Clinical Research Center of Moscow

Grinevich V.N.

Clinical Research Center of Moscow

Received:

28.12.2022

Accepted:

20.06.2023

Close metadata

References:

  1. Peikin SR, Galdibini J, Bartlett JG. Role of clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis. Gastroenterology. 1980;79(5 Pt 1):948-951. 
  2. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases. 2018;66:e1-e48.  https://doi.org/10.1093/cid/cix1085
  3. Bartram CI. Radiology in the current assessment of ulcerative colitis. Gastrointestinal Radiology. 1977;1(4):383-392.  https://doi.org/10.1007/BF02256402
  4. Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC. Assessment of severity in colitis: a preliminary study. Gut. 1975;16(8):579-584.  https://doi.org/10.1136/gut.16.8.579
  5. Ciccocioppo R, Corazza GR. In-hospital mortality for toxic megacolon. Internal and Emergency Medicine. 2018;13(6):837-838.  https://doi.org/10.1007/s11739-018-1919-6
  6. Doshi R, Desai J, Shah Y, Decter D, Doshi S. Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States. Internal and Emergency Medicine. 2018;13(6):881-887.  https://doi.org/10.1007/s11739-018-1889-8
  7. Grundfest-Broniatowski S, Quader M, Alexander F, Walsh RM, Lavery I, Milsom J. Clostridium difficile colitis in the critically ill. Diseases of the Colon and Rectum. 1996;39(6):619-623.  https://doi.org/10.1007/BF02056938
  8. Jalan KN, Sircus W, Card WI, Falconer CW, Bruce CB, Crean GP, McManus JP, Small WP, Smith AN. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology. 1969;57(1):68-82. 
  9. Desai J, Elnaggar M, Hanfy AA, Doshi R. Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions Clinical and Experimental Gastroenterology. 2020;13:203-210.  https://doi.org/10.2147/CEG.S200760
  10. Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G. Clostridium difficile infection: review. European Journal of Clinical Microbiology and Infectious Diseases. 2019;38(7):1211-1221. https://doi.org/10.1007/s10096-019-03539-6
  11. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. Journal of Antimicrobial Chemotherapy. 2012;67(3):742-748.  https://doi.org/10.1093/jac/dkr508
  12. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015; 313(4):398-408.  https://doi.org/10.1001/jama.2014.17103
  13. Zharova ME, Ivanikov IO, Grigorieva YuV, Nikonov EL, Kirillova NCh, Vladimirova NN, Chichva AN, Andreeva OA. Evaluation of diarrhea in COVID-19 patients. Russian Journal of Evidence-Based Gastroenterology. 2022;11(4):46-56. (In Russ.) https://doi.org/10.17116/dokgastro20221104146
  14. Karanika S, Grigoras C, Flokas ME, Alevizakos M, Kinamon T, Kojic EM, Mylonakis E. The attributable burden of Clostridium difficile infection to long-term care facilities stay: a clinical study. Journal of the American Geriatrics Society. 2017;65(8):1733-1740. https://doi.org/10.1111/jgs.14863
  15. Krutova M, Kinross P, Barbut F, Hajdu A, Wilcox MH, Kuijper EJ. How to: surveillance of Clostridium difficile infections. Clinical Microbiology and Infection. 2018;24(5):469-475.  https://doi.org/10.1016/j.cmi.2017.12.008
  16. Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye Gut. 2020;69(6):973-974.  https://doi.org/10.1136/gutjnl-2020-321195
  17. Han C, Duan C, Zhang S, Spiegel B, Shi H, Wang W, Zhang L, Lin R, Liu J, Ding Z, Hou X. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. American Journal of Gastroenterology. 2020;115(6):916-923.  https://doi.org/10.14309/ajg.0000000000000664
  18. McClave SA, DiBaise JK, Mullin GE, Martindale RG. ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient. American Journal of Gastroenterology. 2016;111(3):315-334.  https://doi.org/10.1038/ajg.2016.28
  19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine. 1985;13(10):818-829. 
  20. Cooke C, Kennedy ED, Foo I, Nimmo S, Speake D, Paterson HM, Ventham NT. Meta-analysis of the effect of perioperative intravenous lidocaine on return of gastrointestinal function after colorectal surgery. Techniques in Coloproctology. 2019;23(1):15-24.  https://doi.org/10.1007/s10151-019-1927-1
  21. Greenstein AJ, Bryn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery. 2008;143:623-629.  https://doi.org/10.1016/j.surg.2007.12.008
  22. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews. Immunology. 2020;20(6):363-374.  https://doi.org/10.1038/s41577-020-0311-8
  23. Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterology Report. 2018;6(1):21-28.  https://doi.org/10.1093/gastro/gox041
  24. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Annals of Surgery. 2002;235(3):363-372.  https://doi.org/10.1097/00000658-200203000-00008
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.